medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2016, Number 2

<< Back Next >>

Alerg Asma Inmunol Pediatr 2016; 25 (2)

Eosinophilic gastroenteritis: report of 16 clinical cases

Moreno GHL, Trevizo OL, Moreno TL

Language: Spanish
References: 21
Page: 46-51
PDF size: 138.13 Kb.


ABSTRACT

Eosinophilic enteritis and especially eosinophilic esophagitis is a recently recognized disease and its prevalence is increasing significantly. Eosinophilic esophagitis (EoE) is a disease characterized by aberrant infiltration of eosinophils within the esophageal mucosa. The symptoms of EoE vary with the age of the patient are typically refractory to acid suppressive therapy and manifest as reflux, vomiting, failure and/or refusal to the passage of food, or abdominal pain. The severity is associated with the number of eosinophils found in the esophageal mucosa and the degree of hyperplasia of the esophageal epithelial cells. The cause of EoE is unknown and believed to be a type I hypersensitivity immune response where the food or airborne allergens may be responsible for the physiopathology. This is a clinical and pathological report of 16 cases that were evaluated in the city of Chihuahua in Dermatology and Allergy Clinic in different periods and with various diagnoses in the chapter of eosinophilic enteritis.


REFERENCES

  1. Noel RJ, Putnam PE. Eosinophilic esophagitis. N Engl J Med. 2004; 351 (9): 940-941.

  2. Cianferoni A, Spergel JM. Eosinophilic esophagitis and gastroenteritis. Curr Allergy Asthma Resp. 2015; 15 (9): 58.

  3. Le-Carlson M, Triadafilopoulos G, Pai RK, Kerner JA. An evolving case of concurrent eosinophilic esophagitis and eosinophilic gastroenteritis. Dig Dis Sci. 2012; 57 (4): 842-844.

  4. Arora AA, Weiler CR, Katzka DA. Eosinophilic esophagitis: allergic contribution, testing and management. Curr Gastroenteral Rep. 2012; 14 (3): 206-215.

  5. Eustace G, Gui X, Lacucci M. Recent advances in the recognition and management of eosinophilic esophagitis. Can J Gastroenterol Hepatol. 2015; 29 (5): 237-240.

  6. Rizo PJM, De la Hoz CB, Redondo VC et al. Allergy assessment in children with eosinophilic esophagitis. J Investing Allergol Clin Immunol. 2011; 21 (1): 59-65.

  7. Ally MR, Maydonovitch CL, Betteridge JD, Veerappan GR, Moawad FJ. Prevalence of eosinophilic esophagitis in a United State military health-care population. Dis Esophagus. 2015; 28 (6): 505-511.

  8. De la Cruz-Patiño E, Ruíz JI, Meixueiro DA, Grube PP, Roesch-Diestlon F. Eosinophilic esophagitis prevalence in an adult population undergoing upper endoscopy in southeastern Mexico. Dis Esophagus. 2015; 28 (6): 524-529.

  9. Homan M, Blagus R, Jeverica AK, Orel R. Pediatric eosinophilic esophagitis in slovenia: data from a retrospetive 2005-2012 epidemiological study. J Pediatr Gastroenterol Nutr. 2015; 61 (3): 313-318.

  10. Straumann A, Aceves SS, Blanchard C et al. Pediatric and adult eosinophilic esophagitis: similaritis and differences. Allergy. 2012; 67 (4): 477-490.

  11. Rodrigues M, D’Amico MF, Patiño FR, Barbieri D, Damião AO, Sipahi AM. Clinical manifestations, treatment, and outcoms of children and adolescents witheosinophilic esophagitis. J Pediatr (Rio J). 2013; 89 (2): 197-203.

  12. Krishnan U. Eosinophilic esophagistis in children with esophageal atresia. Eur J Pediatr Surg. 2015; 25 (4): 336-344.

  13. Furuta GT, Liacouras CA, Collins MH et al. Eosinophilic esophagitis in children and adults a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007; 133 (4): 1342-1363.

  14. Dellon ES, Aderoju A, Woosley JT, Sandler RS, Shaheen NJ. La variabilidad en los criterios diagnósticos para la esofagitis eosinofílica. Una revisión sistémica. Am J Gastroenterol. 2007; 102: 2300-2313.

  15. Liacouras CA, Furuta GT, Hirano I et al. Eosinophilic esophagitis: updated consensus recommendations for children’s and adults. J Allergy Clin Immunol. 2011; 128 (1): 3-20. e6; quiz 21-2.

  16. Rothenberg ME, Wan T, Greenberg A, Alpan O, Enav B, Hirano I et al. Intravenous anti-IL-13mAb QAX576-for the treatment of eosinophilic esophagities. J Allergy Clin Immunol. 2015; 135 (2): 500-507.

  17. Wang YH, Hogan SP, Fulkerson PC, Abonia JP, Rothenberg ME. Expanding the paradigman of eosinophilic esophagitis: mast cells and IL-9. J Allergy Clin Immunol. 2013; 131 (6): 1583-1585.

  18. Verdier J, Ruemmele FM. Molecular mechanisms and cell targets of Th17 cells in the gastrointestinal tract: an innate sense of adaptivity. Int Rev Immunol. 2013; 32 (5-6): 475-492.

  19. Dellon ES, Speck O, Woodward K, Covey S, Rusin S, Gebhart JH et al. Markers of eosinphilic inflammation for diagnosis of eosinophilic esophagitis and proton pump. Inhibitor-responsive esophageal eosinophilic: a prospective study. Clin Gastroenterol Hepatol. 2014; 12 (12): 2015-2022.

  20. Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014; 147 (6): 1238-1254.

  21. Epstein J, Warner JO. Recent advances in the pathophysiology and management of eosinophilic oesophagitis. Clin Exp Allergy. 2014; 44 (6): 802-812.




2020     |     www.medigraphic.com